Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • State of the Art
  • Published:

Emerging trends in acquired neonatal intestinal disease: is it time to abandon Bell's criteria?

Abstract

In the last decade, it has become increasingly clear that necrotizing enterocolitis (NEC) is neither a uniform nor a well-defined disease entity. There are many factors that are forcing this unwelcome realization upon the neonatal and pediatric surgery communities. In the course of this manuscript we will review the history and the physical findings of the disparate etiologies of acquired neonatal intestinal diseases (ANIDs), some which do lead to the common final pathology of NEC and some which do not. New guidelines for distinguishing between ANIDs will also be suggested.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3

References

  1. Bell MJ, Ternberg JL, Feigin RD, Keating JP, Marshall R, Barton L et al. Neonatal necrotizing enterocolitis: therapeutic decisions based upon clinical staging. Ann Surg 1978; 187: 1–7.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Kliegman RM, Walsh MC . Neonatal necrotizing enterocolitis: pathogenesis, classification, and spectrum of disease. Curr Probl Pediatr 1987; 17 (4): 243–288.

    Google Scholar 

  3. Kliegman RM . Neonatal necrotizing enterocolitis: implications for an infectious disease. Pediatr Clin North Am 1979; 26 (2): 327–344.

    Article  CAS  PubMed  Google Scholar 

  4. Walsh MC, Kliegman RM . Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am 1986; 33 (1): 179–201.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. Grylack LJ, Scanlon JW . Oral gentamicin therapy in the prevention of neonatal necrotizing enterocolitis. A controlled double-blind trial. Am J Dis Child 1978; 132: 1192–1194.

    Article  CAS  PubMed  Google Scholar 

  6. Boyle R, Nelson JS, Stonestreet BS, Peter G, Oh W . Alterations in stool flora resulting from oral kanamycin prophylaxis of necrotizing enterocolitis. J Pediatr 1978; 93: 857–861.

    Article  CAS  PubMed  Google Scholar 

  7. Schanler RJ, Lau C, Hurst NM, O’Brian Smith E . Randomized trial of donor human milk versus preterm formula as substitutes for mothers’ own milk in the feeding of extremely premature infants. Pediatrics 2005; 116: 400–406.

    Article  PubMed  Google Scholar 

  8. Boyd CA, Quigley MA, Brocklehurst P . Donor breast milk versus infant formula for preterm infants: a systematic review and meta-analysis. Arch Dis Child Fetal Neonatal Ed 2007; 92 (3): F169–F175.

    Article  PubMed  Google Scholar 

  9. Berseth CL, Bisquera JA, Paje VU . Prolonging small feeding volumes early in life decreases the incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2003; 111: 529–534.

    Article  PubMed  Google Scholar 

  10. Lin HC, Su BH, Chen AC, Lin TW, Tsai CH, Yeh TF et al. Oral probiotics reduce the incidence and severity of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2005; 115: 1–4.

    Article  PubMed  Google Scholar 

  11. Bin-Nun A, Bromker R, Wilschanski M, Kaplan M, Rudensky B, Caplan M et al. Oral probiotics prevent necrotizing enterocolitis in very low birth weight neonates. J Pediatr 2005; 147: 192–196.

    Article  PubMed  Google Scholar 

  12. Hoyos AB . Reduced incidence of necrotizing enterocolitis associated with enteral administration of Lactobacillus acidophilus and Bifidobacterium infantis to neonates in an intensive care unit. Int J Infect Dis 1999; 3: 197–202.

    Article  CAS  PubMed  Google Scholar 

  13. Aschner JL, Deluga KS, Metlay LA, Emmens RW, Hendricks-Munoz KD . Spontaneous focal gastrointestinal perforation in very low birth weight infants. J Pediatr 1988; 113: 364–367.

    Article  CAS  PubMed  Google Scholar 

  14. Gordon PV, Young ML, Marshall DD . Focal small bowel perforation: an adverse effect of early postnatal dexamethasone therapy in extremely low birth weight infants. J Perinatol 2001; 21: 156–160.

    Article  CAS  PubMed  Google Scholar 

  15. Schmidt B, Davis P, Moddemann D, Ohlsson A, Roberts RS, Saigal S et al. Long-term effects of indomethacin prophylaxis in extremely-low-birth-weight infants. N Engl J Med 2001; 344: 1966–1972.

    Article  CAS  PubMed  Google Scholar 

  16. Stark AR, Carlo WA, Tyson JE, Papile LA, Wright LL, Shankaran S et al. Adverse effects of early dexamethasone in extremely-low-birth-weight infants. National institute of child health and human development neonatal research network. N Engl J Med 2001; 344: 95–101.

    Article  CAS  PubMed  Google Scholar 

  17. Watterberg KL, Gerdes JS, Cole CH, Aucott SW, Thilo EH, Mammel MC et al. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics 2004; 114: 1649–1657.

    Article  PubMed  Google Scholar 

  18. Attridge JT, Clark R, Walker MW, Gordon PV . New insights into spontaneous intestinal perforation using a national data set: (1) SIP is associated with early indomethacin exposure. J Perinatol 2006; 26: 93–99.

    Article  CAS  PubMed  Google Scholar 

  19. Paquette L, Friedlich P, Ramanathan R, Seri I . Concurrent use of indomethacin and dexamethasone increases the risk of spontaneous intestinal perforation in very low birth weight neonates. J Perinatol 2006; 26: 486–492.

    Article  CAS  PubMed  Google Scholar 

  20. Pumberger W, Mayr M, Kohlhauser C, Weninger M . Spontaneous localized intestinal perforation in very-low-birth-weight infants: a distinct clinical entity different from necrotizing enterocolitis. J Am Coll Surg 2002; 195: 796–803.

    Article  PubMed  Google Scholar 

  21. Okuyama H, Kubota A, Oue T, Kuroda S, Ikegami R, Kamiyama M . A comparison of the clinical presentation and outcome of focal intestinal perforation and necrotizing enterocolitis in very-low-birth-weight neonates. Pediatr Surg Int 2002; 18: 704–706.

    PubMed  Google Scholar 

  22. Buchheit JQ, Stewart DL . Clinical comparison of localized intestinal perforation and necrotizing enterocolitis in neonates. Pediatrics 1994; 93: 32–36.

    CAS  PubMed  Google Scholar 

  23. Adesanya OA, O’Shea TM, Turner CS, Amoroso RM, Morgan TM, Aschner JL . Intestinal perforation in very low birth weight infants: growth and neurodevelopment at 1 year of age. J Perinatol 2005; 25: 583–589.

    Article  PubMed  Google Scholar 

  24. Moss RL, Dimmitt RA, Barnhart DC, Sylvester KG, Brown RL, Powell DM et al. Laparotomy versus peritoneal drainage for necrotizing enterocolitis and perforation. N Engl J Med 2006; 354: 2225–2234.

    Article  CAS  PubMed  Google Scholar 

  25. Schmidt B, Roberts RS, Davis P, Doyle LW, Barrington KJ, Ohlsson A et al. Caffeine therapy for apnea of prematurity. N Engl J Med 2006; 354: 2112–2121.

    Article  CAS  PubMed  Google Scholar 

  26. Kinsella JP, Cutter GR, Walsh WF, Gerstmann DR, Bose CL, Hart C et al. Early inhaled nitric oxide therapy in premature newborns with respiratory failure. N Engl J Med 2006; 355: 404–406.

    Article  Google Scholar 

  27. Blakely ML, Tyson JE, Lally KP, McDonald S, Stoll BJ, Stevenson DK et al. Laparotomy versus peritoneal drainage for necrotizing enterocolitis or isolated intestinal perforation in extremely low birth weight infants: outcomes through 18 months adjusted age. Pediatrics 2006; 117: e680–e687.

    Article  PubMed  Google Scholar 

  28. Blakely ML, Lally KP, McDonald S, Brown RL, Barnhart DC, Ricketts RR et al. Postoperative outcomes of extremely low birth-weight infants with necrotizing enterocolitis or isolated intestinal perforation: a prospective cohort study by the NICHD Neonatal Research Network. Ann Surg 2005; 241: 984–989.

    Article  PubMed  PubMed Central  Google Scholar 

  29. Attridge JT, Clark R, Walker MW, Gordon PV . New insights into spontaneous intestinal perforation using a national data set: (2) two populations of patients with perforations. J Perinatol 2006; 26: 185–188.

    Article  CAS  PubMed  Google Scholar 

  30. Attridge JT, Clark R, Gordon PV . New insights into spontaneous intestinal perforation using a national data set (3): antenatal steroids have no adverse association with spontaneous intestinal perforation. J Perinatol 2006; 26 (11): 667–670.

    Article  CAS  PubMed  Google Scholar 

  31. Guthrie SO, Walsh WF, Auten K, Clark RH . Initial dosing of inhaled nitric oxide in infants with hypoxic respiratory failure. J Perinatol 2004; 24 (5): 290–294.

    Article  CAS  PubMed  Google Scholar 

  32. Garland J, Colleen A, Thomas P, Whitehead V, Brand J, Winston J et al. A three-day course of dexamethasone therapy to prevent chronic lung disease in ventilated neonates: a randomized trial. Pediatrics 1999; 104: 91–99.

    Article  CAS  PubMed  Google Scholar 

  33. Stark AR, Carlo WA, Tyson JE, Papile L-A, Wright LL, Shankaran S et al. Adverse effects of early dexamethasone treatment in extremely-low-birth-weight infants. N Engl J Med 2001; 344: 95–101.

    Article  CAS  PubMed  Google Scholar 

  34. Vermont Oxford Network Steroid Study Group. Early postnatal dexamethasone therapy for the prevention of chronic lung disease. Pediatrics 2001; 108: 741–748.

    Article  Google Scholar 

  35. Sinkin R, Harry D, Horgan M, Gallaher K, Cox C, Maniscalco W et al. Early dexamethasone – attempting to prevent chronic lung disease. Pediatrics 2000; 105: 542–548.

    Article  CAS  PubMed  Google Scholar 

  36. Rastogi A, Akintorin S, Bez M, Morales P, Pildes R . A controlled trial of dexamethasone to prevent bronchopulmonary dysplasia in surfactant-treated infants. Pediatrics 1996; 98: 204–210.

    CAS  PubMed  Google Scholar 

  37. Shinwell E, Karplus M, Zmora E, Reich D, Rothschild A, Blazer S et al. Failure of early postnatal dexamethasone to prevent chronic lung disease in infants with respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed 1996; 74: F33–F37.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  38. Roberts RS . Early closure of the Watterberg trial. Pediatrics 2004; 114 (6): 1670–1671.

    Article  PubMed  Google Scholar 

  39. Watterberg KL, Gerdes JS, Cole CH, Aucott SW, Thilo EH, Mammel MC et al. Prophylaxis of early adrenal insufficiency to prevent bronchopulmonary dysplasia: a multicenter trial. Pediatrics 2004; 114: 1649–1657.

    Article  PubMed  Google Scholar 

  40. Peltoniemi O, Kari MA, Heinonen K, Saarela T, Nikolajev K, Andersson S et al. Pretreatment cortisol values may predict responses to hydrocortisone administration for the prevention of bronchopulmonary dysplasia in high-risk infants. J Pediatr 2005; 146: 632–637.

    Article  CAS  PubMed  Google Scholar 

  41. Efird MM, Heerens AT, Gordon PV, Bose CL, Young DA . A randomized-controlled trial of prophylactic hydrocortisone supplementation for the prevention of hypotension in extremely low birth weight infants. J Perinatol 2005; 25: 119–124.

    Article  CAS  PubMed  Google Scholar 

  42. Anttila E, Peltoniemi O, Haumont D, Herting E, ter Horst H, Heinonen K et al. Early neonatal dexamethasone treatment for prevention of bronchopulmonary dysplasia. Randomised trial and meta-analysis evaluating the duration of dexamethasone therapy. Eur J Pediatr 2005; 164: 472–481.

    Article  CAS  PubMed  Google Scholar 

  43. Ng PC, Lee CH, Bnur FL, Chan IH, Lee AW, Wong E et al. A double-blind, randomized, controlled study of a ‘stress dose’ of hydrocortisone for rescue treatment of refractory hypotension in preterm infants. Pediatrics 2006; 117: 367–375.

    Article  PubMed  Google Scholar 

  44. Yeh TF, Lin YJ, Hsieh WS, Lin HC, Lin CH, Chen JY et al. Early postnatal dexamethasone therapy for the prevention of chronic lung disease in preterm infants with respiratory distress syndrome: a multicenter clinical trial. Pediatrics 1997; 100: E3.

    Article  CAS  PubMed  Google Scholar 

  45. Kopelman AE, Moise AA, Holbert D, Hegemier SE . A single very early dexamethasone dose improves respiratory and cardiovascular adaptation in preterm infants. J Pediatr 1999; 135: 345–350.

    Article  CAS  PubMed  Google Scholar 

  46. Watterberg KL, Gerdes JS, Gifford KL, Lin HM . Prophylaxis against early adrenal insufficiency to prevent chronic lung disease in premature infants. Pediatrics 1999; 104: 1258–1263.

    Article  CAS  PubMed  Google Scholar 

  47. Nowicki PT . Ischemia and necrotizing enterocolitis: where, when, and how. Semin Pediatr Surg 2005; 14: 152–158.

    Article  PubMed  Google Scholar 

  48. Wiswell TE, Robertson CF, Jones TA, Tuttle DJ . Necrotizing enterocolitis in full-term infants. A case–control study. Am J Dis Child 1988; 142: 532–535.

    Article  CAS  PubMed  Google Scholar 

  49. Andrews DA, Sawin RS, Ledbetter DJ, Schaller RT, Hatch EI . Necrotizing enterocolitis in term neonates. Am J Surg 1990; 159: 507–509.

    Article  CAS  PubMed  Google Scholar 

  50. Leung MP, Chau KT, Hui PW, Tam AY, Chan FL, Lai CL et al. Necrotizing enterocolitis in neonates with symptomatic congenital heart disease. J Pediatr 1988; 113: 1044–1046.

    Article  CAS  PubMed  Google Scholar 

  51. Bolisetty S, Lui K, Oei J, Wojtulewicz J . A regional study of underlying congenital diseases in term neonates with necrotizing enterocolitis. Acta Paediatr 2000; 89: 1226–1230.

    Article  CAS  PubMed  Google Scholar 

  52. McElhinney DB, Hedrick HL, Bush DM, Pereira GR, Stafford PW, Gaynor JW et al. Necrotizing enterocolitis in neonates with congenital heart disease: risk factors and outcomes. Pediatrics 2000; 106: 1080–1087.

    Article  CAS  PubMed  Google Scholar 

  53. Lambert DK, Christensen RD, Henry E, Besner GE, Baer VL, Wiedmeier SE et al. Necrotizing enterocolitis in term neonates: data from a multihospital healthcare system. J Perinatol 2007; e-pub ahead of print, 29 March 2007. doi:10.1038/sj.jp.7211738.

  54. Sharma R, Garrison RD, Tepas D, Mollitt DL, Pieper P, Hudak ML et al. Rotavirus-associated necrotizing enterocolitis: an insight into a potentially preventable disease? J Pediatr Surg 2004; 39: 453–457.

    Article  PubMed  Google Scholar 

  55. Keller KM, Schmidt H, Wirth S, Queisser-Luft A, Schumacher R . Differences in the clinical and radiologic patterns of rotavirus and non-rotavirus necrotizing enterocolitis. Pediatr Infect Dis J 1991; 10: 734–738.

    Article  CAS  PubMed  Google Scholar 

  56. Castro R . Echovirus 7 infection and necrotizing enterocolitis-like symptoms in a premature infant. J Perinatol 2000; 20: 558–561.

    Article  CAS  PubMed  Google Scholar 

  57. Shetty A, Barnes R, Lazda E, Doherty C, Maxwell N . Cytomegalovirus: a cause of colonic stricture in a premature infant. J Infect 2007; 54: e37–e39; e-pub ahead of print, 9 May 2006.

    Article  PubMed  Google Scholar 

  58. Dearlove J, Latham P, Dearlove B, Pearl K, Thomson A, Lewis IG . Clinical range of neonatal rotavirus gastroenteritis. Br Med J (Clin Res Ed) 1983; 286: 1473–1475.

    Article  CAS  Google Scholar 

  59. Moss RL, Dimmitt RA, Barnhart DC, Sylvester KG, Brown RL, Powell DM et al. Laparotomy versus peritoneal drainage for necrotizing enterocolitis and perforation. N Engl J Med 2006; 354: 2225–2234.

    Article  CAS  PubMed  Google Scholar 

  60. Gordon PV . Treatment of necrotizing enterocolitis. N Engl J Med 2006; 355: 846–847.

    Article  CAS  PubMed  Google Scholar 

  61. Meinzen-Derr J . A prediction model for risk of necrotizing enterocolitis among very low birth weight infants (dissertation), Department of Environmental Health, University of Cincinnati College of Medicine, 2006.

  62. Bahna SL . Cow's milk allergy versus cow milk intolerance. Ann Allergy Asthma Immunol 2002; 89: 56–60.

    Article  PubMed  Google Scholar 

  63. Sharma R, Hudak ML, Premachandra BR, Stevens G, Monteiro CB, Bradshaw JA et al. Clinical manifestations of rotavirus infection in the neonatal intensive care unit. Pediatr Infect Dis J 2002; 21: 1099–1105.

    Article  PubMed  Google Scholar 

  64. Tam AL, Camberos A, Applebaum H . Surgical decision making in necrotizing enterocolitis and focal intestinal perforation: predictive value of radiologic findings. J Pediatr Surg 2002; 37: 1688–1691.

    Article  PubMed  Google Scholar 

  65. Coates EW, Karlowicz MG, Croitoru DP, Buescher ES . Distinctive distribution of pathogens associated with peritonitis in neonates with focal intestinal perforation compared with necrotizing enterocolitis. Pediatrics 2005; 116: e241–e246.

    Article  PubMed  Google Scholar 

  66. Terry NE, Fowler CL . Cytomegalovirus enterocolitis complicated by perforated appendicitis in a premature infant. J Pediatr Surg 2006; 41: 1476–1478.

    Article  PubMed  Google Scholar 

  67. Pumberger W, Mayr M, Kohlhauser C, Weninger M . Spontaneous localized intestinal perforation in very-low-birth-weight infants: a distinct clinical entity different from necrotizing enterocolitis. J Am Coll Surg 2002; 195: 796–803.

    Article  PubMed  Google Scholar 

  68. Guillet R, Stoll BJ, Cotton CM, Gantz M, McDonald S, Poole WK et al. Association of H2-blocker therapy and higher incidence of necrotizing enterocolitis in very low birth weight infants. Pediatrics 2006; 117: e137–e142.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to P V Gordon.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gordon, P., Swanson, J., Attridge, J. et al. Emerging trends in acquired neonatal intestinal disease: is it time to abandon Bell's criteria?. J Perinatol 27, 661–671 (2007). https://doi.org/10.1038/sj.jp.7211782

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.jp.7211782

Keywords

This article is cited by

Search

Quick links